http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200200563-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2002-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2002-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200200563-A1
titleOfInvention NEW INDENOINDOLON COMPOUNDS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS, THEIR CONTAINING
abstract The compound of formula (I) in which R represents a hydrogen atom, an optionally substituted alkyl group or an alkenyl group, R-R which may be the same or different, each represents a hydrogen atom, or an optionally substituted alkyl group, a hydroxy group, an optionally substituted amino group, a carboxy group, an optionally substituted alkoxy group, or one of the groups from R to R forms with the other of the groups from R to R, which is adjacent, an alkylenedioxy group, X represents an oxygen atom or a group of NR, in which is a hydrogen atom, an alkyl, aryl or aralkyl group; R represents a hydrogen atom, an aryl group, a heteroaryl group or an optionally substituted, saturated or unsaturated alkyl group, their isomers, and their addition salts with a pharmaceutically acceptable acid or base. Medications.
priorityDate 2001-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140446081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411300906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 32.